Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: RaySearch Laboratories AB

Market Cap 754.22Cr 79Cr 69Cr 63Cr 59Cr 110.69Cr 7.57TCr 113Cr 292.01Cr 3.65TCr 296.72Cr 290.32Cr 13TCr P/E Ratio 2026 *
26.4x
P/E Ratio 2027 * 21.2x
Enterprise Value 745.22Cr 78Cr 68Cr 62Cr 59Cr 109.37Cr 7.48TCr 111.65Cr 288.52Cr 3.6TCr 293.18Cr 286.86Cr 13TCr EV / Sales 2026 *
5.29x
EV / Sales 2027 * 4.54x
Free-Float
85.52%
Yield 2026 *
1.82%
Yield 2027 * 2.35%
1 day-2.59%
1 week-5.16%
Current month-2.82%
1 month+20.77%
3 months+12.32%
6 months-7.82%
Current year-6.40%
1 week 209.8
Extreme 209.8
227.6
1 month 173.6
Extreme 173.6
227.6
Current year 166.8
Extreme 166.8
237.2
1 year 166.8
Extreme 166.8
373.5
3 years 55.6
Extreme 55.6
373.5
5 years 40
Extreme 40
373.5
10 years 40
Extreme 40
373.5
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2000
Director of Finance/CFO 48 27/01/2025
Chief Tech/Sci/R&D Officer 53 28/08/2015
Director TitleAgeSince
Director/Board Member 57 01/01/2000
Chairman 81 18/11/2016
Chairman 87 30/09/2022
Date Insider Type Main position Quantity % Market Cap.
17/12Fiscal year

Founder

10,21,577 12.0826%
17/12Fiscal year

Founder

10,21,577 3.5685%
14/11Buy

Director

4,690 0.0164%
Change 5-day change 1-year change 3-year change Capi.($)
-3.00%-5.16%-34.03%+207.94% 80Cr
-0.68%-8.77%-43.53%-14.46% 2.66TCr
+0.75%+1.98%-42.57%+158.07% 1.19TCr
-3.20%+1.89%-8.70%+55.93% 634.54Cr
+5.15%+6.53% - - 253.81Cr
-1.56%-13.81%+23.66%-48.05% 173.64Cr
-1.33%-11.22% - - 168.7Cr
+0.31%-3.48%-34.34% - 125.71Cr
-3.29%-6.12%-35.47%-60.11% 83Cr
+3.80%+7.04%-33.73%-41.17% 76Cr
Average -0.36%+0.64%-26.09%+36.88% 544.08Cr
Weighted average by Cap. -0.50%-2.68%-35.91%+37.70%

Financials

2026 *2027 *
Net sales 140.9Cr 15Cr 13Cr 12Cr 11Cr 21Cr 1.41TCr 21Cr 55Cr 681.52Cr 55Cr 54Cr 2.37TCr 160.3Cr 17Cr 15Cr 13Cr 13Cr 24Cr 1.61TCr 24Cr 62Cr 775.36Cr 63Cr 62Cr 2.7TCr
Net income 28Cr 2.99Cr 2.59Cr 2.39Cr 2.24Cr 4.18Cr 285.98Cr 4.27Cr 11Cr 137.85Cr 11Cr 11Cr 479.32Cr 36Cr 3.72Cr 3.23Cr 2.98Cr 2.79Cr 5.21Cr 356.23Cr 5.32Cr 14Cr 171.71Cr 14Cr 14Cr 597.05Cr
Net Debt -9Cr -94.32L -81.85L -75.45L -70.69L -1.32Cr -90Cr -1.35Cr -3.48Cr -44Cr -3.54Cr -3.46Cr -151.36Cr -26Cr -2.78Cr -2.41Cr -2.22Cr -2.08Cr -3.89Cr -265.91Cr -3.97Cr -10Cr -128.18Cr -10Cr -10Cr -445.68Cr
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
465
Date Price Change Volume
11/26/11 213.40 kr -3.00% 1,50,673
10/26/10 220.00 kr +1.29% 1,51,532
09/26/09 217.20 kr +0.37% 1,29,851
08/26/08 216.40 kr -1.28% 93,008
05/26/05 219.20 kr -2.58% 1,23,296
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
220.00SEK
Average target price
330.00SEK
Spread / Average Target
+50.00%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RAY B Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!